mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
7e-05 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
7e-05 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
8e-05 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0001 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
0.0002 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |